TEMC CNS Co., Ltd. (KOSDAQ:241790)
South Korea · Delayed Price · Currency is KRW 7,220.00
-310.00 (-4.12%)
At close: Apr 9, 2026
TEMC CNS Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 168,041 | 193,532 | 140,337 | 164,969 | 93,940 |
Other Revenue | -0 | -0 | - | -0 | -0 |
| 168,041 | 193,532 | 140,337 | 164,969 | 93,940 | |
Revenue Growth (YoY) | -13.17% | 37.91% | -14.93% | 75.61% | 2.52% |
Cost of Revenue | 140,924 | 168,514 | 111,805 | 130,028 | 68,520 |
Gross Profit | 27,116 | 25,018 | 28,531 | 34,941 | 25,420 |
Selling, General & Admin | 10,610 | 12,188 | 9,262 | 7,791 | 6,752 |
Research & Development | 3,939 | 3,418 | 2,584 | 2,174 | 1,608 |
Amortization of Goodwill & Intangibles | 1,730 | 1,706 | 1,678 | 1,013 | 44.22 |
Other Operating Expenses | 284.05 | 256.85 | 251.74 | 197.62 | 162.48 |
Operating Expenses | 18,119 | 19,086 | 15,228 | 12,150 | 9,399 |
Operating Income | 8,998 | 5,932 | 13,304 | 22,791 | 16,022 |
Interest Expense | -849.86 | -1,100 | -689.57 | -514.55 | -36.12 |
Interest & Investment Income | 583.23 | 600.15 | 930.59 | 99.45 | 1,318 |
Earnings From Equity Investments | 30.78 | - | - | - | - |
Currency Exchange Gain (Loss) | -1,520 | 5,741 | 126.79 | -1,275 | 1,222 |
Other Non Operating Income (Expenses) | -789.96 | -273.11 | -120.32 | -107.99 | 37.61 |
EBT Excluding Unusual Items | 6,452 | 10,900 | 13,551 | 20,993 | 18,564 |
Gain (Loss) on Sale of Investments | 211.91 | -174.21 | 1,784 | -1,254 | -532.61 |
Gain (Loss) on Sale of Assets | 227.88 | 226.4 | -14.69 | 11.26 | 25.55 |
Pretax Income | 6,892 | 10,952 | 15,321 | 19,751 | 18,056 |
Income Tax Expense | 2,630 | 2,215 | 3,324 | 3,967 | 3,422 |
Earnings From Continuing Operations | 4,261 | 8,737 | 11,997 | 15,784 | 14,634 |
Minority Interest in Earnings | -56.42 | 737.22 | 985.79 | -1,349 | -1,310 |
Net Income | 4,205 | 9,475 | 12,983 | 14,435 | 13,324 |
Net Income to Common | 4,205 | 9,475 | 12,983 | 14,435 | 13,324 |
Net Income Growth | -55.62% | -27.02% | -10.06% | 8.34% | -6.35% |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 |
Shares Change (YoY) | -1.21% | 0.09% | 0.07% | -1.48% | -0.39% |
EPS (Basic) | 438.00 | 975.00 | 1337.18 | 1488.21 | 1354.01 |
EPS (Diluted) | 438.00 | 975.00 | 1337.00 | 1488.00 | 1353.00 |
EPS Growth | -55.08% | -27.08% | -10.15% | 9.98% | -5.98% |
Free Cash Flow | 13,195 | 1,370 | -12,536 | 30,183 | 2,758 |
Free Cash Flow Per Share | 1374.37 | 140.95 | -1291.21 | 3110.78 | 280.09 |
Gross Margin | 16.14% | 12.93% | 20.33% | 21.18% | 27.06% |
Operating Margin | 5.35% | 3.06% | 9.48% | 13.81% | 17.05% |
Profit Margin | 2.50% | 4.90% | 9.25% | 8.75% | 14.18% |
Free Cash Flow Margin | 7.85% | 0.71% | -8.93% | 18.30% | 2.94% |
EBITDA | 16,473 | 13,318 | 20,212 | 26,785 | 18,872 |
EBITDA Margin | 9.80% | 6.88% | 14.40% | 16.24% | 20.09% |
D&A For EBITDA | 7,475 | 7,386 | 6,908 | 3,994 | 2,850 |
EBIT | 8,998 | 5,932 | 13,304 | 22,791 | 16,022 |
EBIT Margin | 5.35% | 3.06% | 9.48% | 13.81% | 17.05% |
Effective Tax Rate | 38.17% | 20.22% | 21.70% | 20.08% | 18.95% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.